Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2021/1646364 http://scihub22266oqcxt.onion/10.1155/2021/1646364 34367705!8346294!34367705     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34367705&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Case+Rep+Ophthalmol+Med 2021 ; 2021 (?): 1646364 Nephropedia Template TP {{tp|p=34367705|t=2021. Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infection |pdf=|usr=}}{{34367705}} gab.com Text Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infection JO: Case Rep Ophthalmol Med http://www.kidney.de/pget.php?&tw=1&pmid=34367705 #FOAvip PURPOSE: To report a case of bilateral ampiginous choroiditis following presumed SARS-CoV-2 infection. Case Description. A 25-year-old woman presented with metamorphopsia and a paracentral scotoma in her left eye. She endorsed night sweats, headache, and new-onset anosmia beginning 1 week before her visual symptoms. She also had multiple confirmed ill COVID-19 contacts at her workplace before the onset of her symptoms. Funduscopic examination and multimodal imaging revealed placoid lesions in the macula and midperiphery of both eyes consistent with ampiginous choroiditis. COVID-19 antibody testing returned positive for IgG, and an extensive systemic evaluation was otherwise unremarkable. She was treated with oral prednisone and azathioprine with stabilization of the retinal lesions and no progression of her symptoms. CONCLUSIONS: Ampiginous choroiditis is an inflammatory chorioretinopathy with an unknown pathogenic mechanism that often necessitates early immunomodulatory therapy. This report suggests that SARS-CoV-2 infection may trigger chorioretinal inflammation in susceptible hosts. Twit Text FOAVip Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infection ????Case Rep Ophthalmol Med http://www.kidney.de/pget.php?&tw=1&pmid=34367705 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34367705 #FOAvip English Wikipedia <ref>{{Cite pmid|34367705}}</ref> Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infection #MMPMID34367705 Tom ES; McKay KM; Saraf SS Case Rep Ophthalmol Med 2021[]; 2021 (?): 1646364 PMID34367705show ga PURPOSE: To report a case of bilateral ampiginous choroiditis following presumed SARS-CoV-2 infection. Case Description. A 25-year-old woman presented with metamorphopsia and a paracentral scotoma in her left eye. She endorsed night sweats, headache, and new-onset anosmia beginning 1 week before her visual symptoms. She also had multiple confirmed ill COVID-19 contacts at her workplace before the onset of her symptoms. Funduscopic examination and multimodal imaging revealed placoid lesions in the macula and midperiphery of both eyes consistent with ampiginous choroiditis. COVID-19 antibody testing returned positive for IgG, and an extensive systemic evaluation was otherwise unremarkable. She was treated with oral prednisone and azathioprine with stabilization of the retinal lesions and no progression of her symptoms. CONCLUSIONS: Ampiginous choroiditis is an inflammatory chorioretinopathy with an unknown pathogenic mechanism that often necessitates early immunomodulatory therapy. This report suggests that SARS-CoV-2 infection may trigger chorioretinal inflammation in susceptible hosts. ?Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infecti(epmc).pdf DeepDyve Pubget Overpricing